This announcement is a separate document:
信立泰：华英证券有限责任公司关于深圳信立泰药业股份有限公司控股子公司拟实施股权激励计划暨关联交易的核查意见
Xinlitai: Verification opinion of Huaying Securities Co., Ltd. on the proposed implementation of equity incentive plans and related transactions by the holding subsidiary of Shenzhen Xinlitai Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.